UPDATE: Roth Capital Starts Corvus Pharmaceuticals (CRVS) at Buy
Tweet Send to a Friend
(Updated - May 28, 2019 4:24 PM EDT)
Roth Capital analyst Tony Butler initiates coverage on Corvus Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Tony Butler initiates coverage on Corvus Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
